亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Advances in CAR T Cell Therapy for Non-Small Cell Lung Cancer

嵌合抗原受体 癌症研究 细胞疗法 医学 T细胞 免疫疗法 表皮生长因子受体 抗原 癌症 免疫学 干细胞 生物 内科学 免疫系统 细胞生物学
作者
Hong Ma,Jeeban P. Das,Conor Prendergast,Dorine de Jong,Brian Braumuller,Jacienta Paily,Sophia Huang,Connie Liou,Anna O. Giarratana,Mahdie Hosseini,Randy Yeh,Kathleen M. Capaccione
出处
期刊:Current Issues in Molecular Biology [Caister Academic Press]
卷期号:45 (11): 9019-9038 被引量:31
标识
DOI:10.3390/cimb45110566
摘要

Since its first approval by the FDA in 2017, tremendous progress has been made in chimeric antigen receptor (CAR) T cell therapy, the adoptive transfer of engineered, CAR-expressing T lymphocyte. CAR T cells are all composed of three main elements: an extracellular antigen-binding domain, an intracellular signaling domain responsible for T cell activation, and a hinge that joins these two domains. Continuous improvement has been made in CARs, now in their fifth generation, particularly in the intracellular signaling domain responsible for T cell activation. CAR T cell therapy has revolutionized the treatment of hematologic malignancies. Nonetheless, the use of CAR T cell therapy for solid tumors has not attained comparable levels of success. Here we review the challenges in achieving effective CAR T cell therapy in solid tumors, and emerging CAR T cells that have shown great promise for non-small cell lung cancer (NSCLC). A growing number of clinical trials have been conducted to study the effect of CAR T cell therapy on NSCLC, targeting different types of surface antigens. They include epidermal growth factor receptor (EGFR), mesothelin (MSLN), prostate stem cell antigen (PSCA), and mucin 1 (MUC1). Potential new targets such as erythropoietin-producing hepatocellular carcinoma A2 (EphA2), tissue factor (TF), and protein tyrosine kinase 7 (PTK7) are currently under investigation in clinical trials. The challenges in developing CAR T for NSCLC therapy and other approaches for enhancing CAR T efficacy are discussed. Finally, we provide our perspective on imaging CAR T cell action by reviewing the two main radionuclide-based CAR T cell imaging techniques, the direct labeling of CAR T cells or indirect labeling via a reporter gene.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Eriii应助科研通管家采纳,获得10
3秒前
10秒前
9527发布了新的文献求助10
15秒前
顺心的伯云完成签到,获得积分10
38秒前
Jackey完成签到,获得积分10
1分钟前
默默的以柳完成签到,获得积分10
1分钟前
Eriii应助科研通管家采纳,获得10
2分钟前
wanci应助科研通管家采纳,获得10
2分钟前
顾矜应助科研通管家采纳,获得10
2分钟前
英俊的铭应助科研通管家采纳,获得20
2分钟前
2分钟前
ZHOU发布了新的文献求助10
2分钟前
ZYD完成签到 ,获得积分10
2分钟前
ZHOU完成签到,获得积分10
2分钟前
开放的乐驹完成签到 ,获得积分10
3分钟前
可爱的函函应助花椰菜采纳,获得10
4分钟前
Eriii应助科研通管家采纳,获得10
4分钟前
4分钟前
酷波er应助SW采纳,获得10
4分钟前
内向忆南发布了新的文献求助10
4分钟前
内向忆南完成签到,获得积分10
4分钟前
胡萝卜完成签到,获得积分10
4分钟前
5分钟前
科研通AI6.4应助Blue采纳,获得10
5分钟前
5分钟前
5分钟前
Blue发布了新的文献求助10
5分钟前
Blue完成签到,获得积分10
6分钟前
慕青应助科研通管家采纳,获得30
6分钟前
6分钟前
SW发布了新的文献求助10
6分钟前
6分钟前
zxdzaz完成签到 ,获得积分10
6分钟前
SW完成签到,获得积分10
7分钟前
8分钟前
Eriii应助科研通管家采纳,获得10
8分钟前
在水一方应助科研通管家采纳,获得10
8分钟前
8分钟前
8分钟前
9分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
晶种分解过程与铝酸钠溶液混合强度关系的探讨 8888
Les Mantodea de Guyane Insecta, Polyneoptera 2000
The Organometallic Chemistry of the Transition Metals 800
Leading Academic-Practice Partnerships in Nursing and Healthcare: A Paradigm for Change 800
Signals, Systems, and Signal Processing 610
The formation of Australian attitudes towards China, 1918-1941 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6418780
求助须知:如何正确求助?哪些是违规求助? 8238334
关于积分的说明 17502017
捐赠科研通 5471681
什么是DOI,文献DOI怎么找? 2890861
邀请新用户注册赠送积分活动 1867580
关于科研通互助平台的介绍 1704608